Steven Cohen United Therapeutics Corp Transaction History

Point72 Asset Management, L.P.

$36 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$210.76 - $249.51 $34.3 Million - $40.6 Million	162,700 New	162,700 $37.4 Million
Q3 2023 Nov 14, 2023	SELL	$211.82 - $248.24 $2.3 Million - $2.7 Million	-10,863 Reduced 91.29%	1,037 $234,000
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $2.44 Million - $2.77 Million	11,900 New	11,900 $2.63 Million
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $31 Million - $42.8 Million	-177,285 Reduced 89.95%	19,815 $4.67 Million
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $1.68 Million - $2.16 Million	-10,100 Reduced 4.87%	197,100 $35.4 Million
Q4 2021 Feb 14, 2022	BUY	$184.32 - $216.08 $55,296 - $64,824	300 Added 0.14%	207,200 $44.8 Million
Q3 2021 Nov 15, 2021	SELL	$179.86 - $214.88 $62.1 Million - $74.2 Million	-345,500 Reduced 62.55%	206,900 $38.2 Million
Q2 2021 Aug 16, 2021	BUY	$170.47 - $211.93 $94.2 Million - $117 Million	552,400 New	552,400 $99.1 Million
Q1 2021 May 17, 2021	SELL	$153.94 - $174.85 $52.8 Million - $60 Million	-343,201 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$101.87 - $151.79 $9.91 Million - $14.8 Million	-97,326 Reduced 22.09%	343,201 $52.1 Million
Q3 2020 Nov 16, 2020	BUY	$99.9 - $121.13 $17.1 Million - $20.7 Million	171,218 Added 63.58%	440,527 $44.5 Million
Q2 2020 Aug 14, 2020	SELL	$92.74 - $125.82 $28.7 Million - $39 Million	-309,839 Reduced 53.5%	269,309 $32.6 Million
Q1 2020 May 15, 2020	BUY	$79.39 - $115.35 $46 Million - $66.8 Million	579,148 New	579,148 $54.9 Million
Q4 2019 Feb 14, 2020	SELL	$78.31 - $95.34 $50.1 Million - $61 Million	-640,243 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$74.85 - $85.99 $13.5 Million - $15.5 Million	180,803 Added 39.35%	640,243 $51.1 Million
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $34.9 Million - $55.5 Million	459,440 New	459,440 $35.9 Million
Q1 2019 May 15, 2019	SELL	$107.15 - $126.84 $14.3 Million - $17 Million	-133,643 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$101.4 - $128.73 $13.6 Million - $17.2 Million	133,643 New	133,643 $14.6 Million
Q3 2018 Nov 14, 2018	SELL	$113.81 - $129.46 $315,936 - $359,380	-2,776 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$101.14 - $118.31 $135,123 - $158,062	-1,336 Reduced 32.49%	2,776 $314,000
Q1 2018 May 15, 2018	SELL	$107.21 - $151.94 $20.1 Million - $28.5 Million	-187,887 Reduced 97.86%	4,112 $462,000
Q4 2017 Feb 14, 2018	BUY	$118.58 - $151.28 $22.8 Million - $29 Million	191,999	191,999 $28.4 Million

Others Institutions Holding UTHR

# of Institutions

619

Shares Held

45M

Call Options Held

368K

Put Options Held

410K

Black Rock Inc. New York, NY

5.47M
Shares

$1.96 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

4.42M
Shares

$1.58 Billion
0.03% of portfolio
Wellington Management Group LLP Boston, MA

3.29M
Shares

$1.18 Billion
0.19% of portfolio
Avoro Capital Advisors LLC New York, NY

2.86M
Shares

$1.02 Billion
12.43% of portfolio
State Street Corp Boston, MA

2.29M
Shares

$823 Million
0.03% of portfolio

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account